Insights

Here’s why the Telix (ASX:TLX) share price is crashing 14% lower

This high flying biotech is having an off-day…
The post Here’s why the Telix (ASX:TLX) share price is crashing 14% lower appeared first on The Motley Fool Australia. –

The Telix Pharmaceuticals Ltd (ASX: TLX) share price has been among the worst performers on the All Ordinaries on Monday.

The biopharmaceutical company’s shares were down as much as 14% to $5.53 at one stage.

Despite this, the Telix share price is still up more than 300% over the last 12 months.

Why is the Telix share price crashing today?

The weakness in the Telix share price on Monday appears to be due to a combination of broad market weakness, profit taking, and slight concerns over a study update this morning.

In respect to the latter, this morning Telix released an update on its study of TLX101 in combination with external beam radiation therapy in recurrent glioblastoma multiforme.

According to the release, Telix has decided to cease recruitment after dosing a tenth patient in this recurrent disease (second line) treatment setting. This was well short of its original recruitment target.

Nevertheless, the company has been pleased with the interim analysis of safety and preliminary efficacy. It feels the data is sufficiently encouraging to warrant study in front-line therapy, where radiation therapy is more extensively used.

What is TLX101?

TLX101 is currently under evaluation for the treatment of recurrent glioblastoma multiforme at five sites across Australia and Europe. Recurrent glioblastoma is a highly aggressive cancer that progresses rapidly and has very few effective treatment options.

Telix’s Chief Medical Officer, Dr. Colin Hayward, commented: “We are highly encouraged by the safety profile of this single arm dose-escalation study, where different dosing regimens have been combined with external radiation therapy.”

“Whilst a small study of ten patients, promising overall survival and anti-tumour response observed from longitudinal imaging supports the decision to progress this candidate into an earlier line of therapy. A follow-on study is currently in planning to accelerate the development of TLX101 in this important therapy area with high unmet medical need,” he added.

The post Here’s why the Telix (ASX:TLX) share price is crashing 14% lower appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of May 24th 2021

More reading

Why Bigtincan, Opthea, Seven West Media, & Telix shares are charging higher

Telix (ASX:TLX) share price lower despite key FDA update
Here are 2 mid cap ASX shares to watch closely

Telix (ASX:TLX) share price backtracks despite positive update
The Telix (ASX:TLX) share price has rocketed 12% today. Here’s why.

James Mickleboro owns Telix shares. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!